# Provectus Biopharmaceuticals, Inc.: Form 10-K/A for the period ended Dec 31, 2023

- Company: [Provectus Biopharmaceuticals, Inc.](/companies/pvct.md) (CIK 315545)
- Form: 10-K/A
- Filed: 2024-04-29
- Accepted by EDGAR: Apr 29, 2024, 13:10 ET
- Period: 2023-12-31
- Accession: 0001493152-24-016883
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/315545/000149315224016883/form10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/315545/000149315224016883/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/315545/000149315224016883/form10ka.htm

Filed Apr 29, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-016883. Last ingested by Listed: Oct 30, 2026, 11:33 ET. No prices; not investment advice.